|
||
|
Segmentation of drugs subject to reimbursement in 2022 (Register 3) by manufacturer. |
|
||||||||
| Part of: Vlasenko I, Davtian L (2023) Study of the influence of armed conflict on the reimbursement of oral glucose lowering drugs in Ukraine. Pharmacia 70(2): 275-281. https://doi.org/10.3897/pharmacia.70.e99657 |